Clinical	Clinical	JJ	B-NP	B-protein	
factors	factor	NNS	I-NP	I-protein	
associated	associate	VBN	B-VP	O	
with	with	IN	B-PP	O	
development	development	NN	B-NP	O	
of	of	IN	B-PP	O	
severe	severe	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
complicated	complicate	VBN	I-NP	O	
Clostridium difficile	Clostridium_difficile	NN	I-NP	O	
infection	infection	NN	I-NP	O	
.	.	.	O	O	

Clostridium difficile	Clostridium_difficile	NN	B-NP	O	
infection	infection	NN	I-NP	O	
(	(	(	O	O	
CDI	CDI	NN	B-NP	B-protein	
)	)	)	O	O	
can	can	MD	B-VP	O	
cause	cause	VB	I-VP	O	
life	life	NN	B-NP	O	
-	-	HYPH	O	O	
threatening	threaten	VBG	B-VP	O	
complications	complication	NNS	B-NP	O	
.	.	.	O	O	

Severe	Severe	NN	B-NP	O	
-	-	HYPH	B-PP	O	
complicated	complicate	VBN	B-NP	O	
CDI	CDI	NN	I-NP	B-protein	
is	be	VBZ	B-VP	O	
characterized	characterize	VBN	I-VP	O	
by	by	IN	B-PP	O	
hypotension	hypotension	NN	B-NP	O	
,	,	,	O	O	
shock	shock	NN	B-NP	O	
,	,	,	O	O	
sepsis	sepsis	NN	B-NP	O	
,	,	,	O	O	
ileus	ileus	NN	B-NP	O	
,	,	,	O	O	
megacolon	megacolon	NN	B-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
colon	colon	NN	B-NP	O	
perforation	perforation	NN	I-NP	O	
.	.	.	O	O	

We	We	PRP	B-NP	O	
created	create	VBD	B-VP	O	
a	a	DT	B-NP	O	
model	model	NN	I-NP	O	
to	to	TO	B-VP	O	
identify	identify	VB	I-VP	O	
clinical	clinical	JJ	B-NP	O	
factors	factor	NNS	I-NP	O	
associated	associate	VBN	B-VP	O	
with	with	IN	B-PP	O	
severe	severe	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
complicated	complicate	VBN	B-VP	O	
CDI	CDI	NNP	B-NP	O	
.	.	.	O	O	

We	We	PRP	B-NP	O	
analyzed	analyze	VBD	B-VP	O	
data	datum	NNS	B-NP	O	
from	from	IN	B-PP	O	
1446	1446	CD	B-NP	O	
inpatient	inpatient	NN	I-NP	O	
cases	case	NNS	I-NP	O	
of	of	IN	B-PP	O	
CDI	CDI	NN	B-NP	O	
(	(	(	O	O	
48.6	48.6	CD	B-NP	O	
%	%	NN	I-NP	O	
female	female	NN	I-NP	O	
;	;	:	O	O	
median	median	JJ	B-NP	O	
age	age	NN	I-NP	O	
,	,	,	O	O	
62.5	62.5	CD	B-NP	O	
years	year	NNS	I-NP	O	
;	;	:	O	O	
range	range	NN	B-NP	O	
,	,	,	O	O	
0.1-103.7	0.1-103.7	CD	B-NP	O	
years	year	NNS	I-NP	O	
)	)	)	O	O	
at	at	IN	B-PP	O	
the	the	DT	B-NP	O	
Mayo	Mayo	NNP	I-NP	O	
Clinic	Clinic	NNP	I-NP	O	
from	from	IN	B-PP	O	
June	June	NNP	B-NP	O	
28	28	CD	I-NP	O	
,	,	,	I-NP	O	
2007	2007	CD	I-NP	O	
,	,	,	O	O	
to	to	TO	B-PP	O	
June	June	NNP	B-NP	O	
25	25	CD	I-NP	O	
,	,	,	I-NP	O	
2010	2010	CD	I-NP	O	
.	.	.	O	O	

Patients	Patient	NNS	B-NP	O	
with	with	IN	B-PP	O	
severe	severe	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
complicated	complicate	VBN	I-NP	O	
CDI	CDI	NN	I-NP	O	
(	(	(	O	O	
n =	n =	NN	B-NP	B-protein	
487	487	CD	I-NP	I-protein	
)	)	)	O	O	
were	be	VBD	B-VP	O	
identified	identify	VBN	I-VP	O	
as	as	IN	B-PP	O	
those	those	DT	B-NP	O	
who	who	WP	B-NP	O	
required	require	VBD	B-VP	O	
admission	admission	NN	B-NP	O	
to	to	TO	B-PP	O	
the	the	DT	B-NP	O	
intensive	intensive	JJ	I-NP	O	
care	care	NN	I-NP	O	
unit	unit	NN	I-NP	O	
or	or	CC	O	O	
colectomy	colectomy	NN	B-NP	O	
,	,	,	O	O	
or	or	CC	O	O	
died	die	VBD	B-VP	O	
,	,	,	O	O	
within	within	IN	B-PP	O	
30	30	CD	B-NP	O	
days	day	NNS	I-NP	O	
of	of	IN	B-PP	O	
CDI	CDI	NN	B-NP	O	
diagnosis	diagnosis	NN	I-NP	O	
.	.	.	O	O	

Logistic	Logistic	JJ	B-NP	O	
regression	regression	NN	I-NP	O	
models	model	NNS	I-NP	O	
were	be	VBD	B-VP	O	
used	use	VBN	I-VP	O	
to	to	TO	B-VP	O	
identify	identify	VB	I-VP	O	
variables	variable	NNS	B-NP	O	
that	that	WDT	B-NP	O	
were	be	VBD	B-VP	O	
independently	independently	RB	I-VP	O	
associated	associate	VBN	I-VP	O	
with	with	IN	B-PP	O	
the	the	DT	B-NP	O	
occurrence	occurrence	NN	I-NP	O	
of	of	IN	B-PP	O	
severe	severe	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
complicated	complicate	VBN	I-NP	O	
CDI	CDI	NN	I-NP	B-protein	
in	in	IN	B-PP	O	
2	2	CD	B-NP	O	
cohorts	cohort	NNS	I-NP	O	
.	.	.	O	O	

One	One	CD	B-NP	O	
cohort	cohort	NN	I-NP	O	
comprised	comprise	VBD	B-VP	O	
all	all	DT	B-NP	O	
hospitalized	hospitalize	VBN	I-NP	O	
patients	patient	NNS	I-NP	O	
;	;	:	O	O	
the	the	DT	B-NP	O	
other	other	JJ	I-NP	O	
comprised	comprise	VBD	B-VP	O	
a	a	DT	B-NP	O	
subset	subset	NN	I-NP	O	
of	of	IN	B-PP	O	
these	these	DT	B-NP	O	
inpatients	inpatient	NNS	I-NP	O	
who	who	WP	B-NP	O	
were	be	VBD	B-VP	O	
residents	resident	NNS	B-NP	O	
of	of	IN	B-PP	O	
Olmsted County	Olmsted_County	NNP	B-NP	O	
,	,	,	O	O	
Minnesota	Minnesota	NNP	B-NP	O	
to	to	TO	B-VP	O	
assess	assess	VB	I-VP	O	
the	the	DT	B-NP	O	
association	association	NN	I-NP	O	
of	of	IN	B-PP	O	
comorbid	comorbid	JJ	B-NP	O	
conditions	condition	NNS	I-NP	O	
with	with	IN	B-PP	O	
the	the	DT	B-NP	O	
development	development	NN	I-NP	O	
of	of	IN	B-PP	O	
severe	severe	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
complicated	complicate	VBN	I-NP	O	
infection	infection	NN	I-NP	O	
in	in	IN	B-PP	O	
a	a	DT	B-NP	O	
population	population	NN	I-NP	O	
-	-	HYPH	O	O	
based	base	VBN	B-VP	O	
cohort	cohort	JJ	B-ADJP	O	
.	.	.	O	O	

The	The	DT	B-NP	O	
linear	linear	JJ	I-NP	O	
combinations	combination	NNS	I-NP	O	
of	of	IN	B-PP	O	
variables	variable	NNS	B-NP	O	
identified	identify	VBN	B-VP	O	
by	by	IN	B-PP	O	
using	use	VBG	B-VP	O	
logistic	logistic	JJ	B-NP	O	
regression	regression	NN	I-NP	O	
models	model	NNS	I-NP	O	
provided	provide	VBD	B-VP	O	
scores	score	NNS	B-NP	O	
to	to	TO	B-VP	O	
predict	predict	VB	I-VP	O	
the	the	DT	B-NP	O	
risk	risk	NN	I-NP	O	
of	of	IN	B-PP	O	
developing	develop	VBG	B-VP	O	
severe	severe	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
complicated	complicate	VBN	B-VP	O	
CDI	CDI	NNP	B-NP	O	
.	.	.	O	O	

In	In	IN	B-PP	O	
a	a	DT	B-NP	O	
multivariable	multivariable	JJ	I-NP	O	
model	model	NN	I-NP	O	
that	that	WDT	B-NP	O	
included	include	VBD	B-VP	O	
all	all	DT	B-NP	O	
inpatients	inpatient	NNS	I-NP	O	
,	,	,	O	O	
increasing	increase	VBG	B-VP	O	
age	age	NN	B-NP	O	
,	,	,	O	O	
leukocyte	leukocyte	NN	B-NP	O	
count	count	NN	I-NP	O	
>15 × 10(9)	>15 × 10(9)	NN	I-NP	O	
/	/	SYM	B-VP	O	
L	L	NN	B-NP	O	
,	,	,	O	O	
increase	increase	NN	B-NP	O	
in	in	IN	B-PP	O	
serum	serum	NN	B-NP	O	
level	level	NN	I-NP	O	
of	of	IN	B-PP	O	
creatinine	creatinine	NN	B-NP	O	
>	>	SYM	B-NP	O	
1.5	1.5	CD	I-NP	O	
-	-	HYPH	B-VP	O	
fold	fold	RB	B-ADVP	O	
from	from	IN	B-PP	O	
baseline	baseline	NN	B-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
use	use	NN	B-NP	O	
of	of	IN	B-PP	O	
proton	proton	NN	B-NP	O	
pump	pump	NN	I-NP	O	
inhibitors	inhibitor	NNS	I-NP	O	
or	or	CC	O	O	
narcotic	narcotic	JJ	B-NP	O	
medications	medication	NNS	I-NP	O	
were	be	VBD	B-VP	O	
independently	independently	RB	I-VP	O	
associated	associate	VBN	I-VP	O	
with	with	IN	B-PP	O	
severe	severe	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
complicated	complicate	VBN	B-VP	O	
CDI	CDI	NNP	B-NP	O	
.	.	.	O	O	

In	In	IN	B-PP	O	
the	the	DT	B-NP	O	
secondary	secondary	JJ	I-NP	O	
analysis	analysis	NN	I-NP	O	
,	,	,	O	O	
which	which	WDT	B-NP	O	
included	include	VBD	B-VP	O	
only	only	RB	B-NP	O	
patients	patient	NNS	I-NP	O	
from	from	IN	B-PP	O	
Olmsted County	Olmsted_County	NNP	B-NP	O	
,	,	,	O	O	
comorbid	comorbid	JJ	B-NP	O	
conditions	condition	NNS	I-NP	O	
were	be	VBD	B-VP	O	
not	not	RB	I-VP	O	
significantly	significantly	RB	I-VP	O	
associated	associate	VBN	I-VP	O	
with	with	IN	B-PP	O	
severe	severe	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
complicated	complicate	VBN	B-VP	O	
CDI	CDI	NNP	B-NP	O	
.	.	.	O	O	

Older	Old	JJR	B-NP	O	
age	age	NN	I-NP	O	
,	,	,	O	O	
high	high	JJ	B-NP	O	
numbers	number	NNS	I-NP	O	
of	of	IN	B-PP	O	
leukocytes	leukocyte	NNS	B-NP	B-cell_type	
in	in	IN	B-PP	O	
blood	blood	NN	B-NP	B-cell_type	
samples	sample	NNS	I-NP	I-cell_type	
,	,	,	O	O	
an	an	DT	B-NP	O	
increased	increase	VBN	I-NP	O	
serum	serum	NN	I-NP	O	
level	level	NN	I-NP	O	
of	of	IN	B-PP	O	
creatinine	creatinine	NN	B-NP	O	
,	,	,	O	O	
gastric	gastric	JJ	B-NP	O	
acid	acid	NN	I-NP	O	
suppression	suppression	NN	I-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
use	use	NN	B-NP	O	
of	of	IN	B-PP	O	
narcotic	narcotic	JJ	B-NP	O	
medications	medication	NNS	I-NP	O	
were	be	VBD	B-VP	O	
independently	independently	RB	I-VP	O	
associated	associate	VBN	I-VP	O	
with	with	IN	B-PP	O	
development	development	NN	B-NP	O	
of	of	IN	B-PP	O	
severe	severe	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
complicated	complicate	VBN	I-NP	O	
CDI	CDI	NN	I-NP	B-protein	
in	in	IN	B-PP	O	
hospitalized	hospitalize	VBN	B-NP	O	
patients	patient	NNS	I-NP	O	
.	.	.	O	O	

Early	Early	RB	B-NP	O	
aggressive	aggressive	JJ	I-NP	O	
monitoring	monitoring	NN	I-NP	O	
and	and	CC	I-NP	O	
intervention	intervention	NN	I-NP	O	
could	could	MD	B-VP	O	
improve	improve	VB	I-VP	O	
outcomes	outcome	NNS	B-NP	O	
.	.	.	O	O	

